Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab

Journal of Neuro-Oncology

Volumn 126, Issue 2, 2016, Pages 355-360

  Frenard, C ^a   Peuvrel, L ^a   Saint Jean, M ^a   Brocard, A ^a   Knol, A C ^a   Nguyen, J M ^a   Khammari, A ^a   Quereux, G ^a   Dreno, B ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Brain metastases; Ipilimumab; Melanoma

Indexed keywords

B RAF KINASE INHIBITOR; CARBOPLATIN; DACARBAZINE; FOTEMUSTINE; IPILIMUMAB; VEMURAFENIB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; BRAIN NEOPLASMS; DISEASE COURSE; IMMUNOLOGY; MELANOMA; PATHOLOGY; SECONDARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84945578017     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1977-9     Document Type: Article

References (26)

1. Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW, Bray F (2013) International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int J Cancer 132: 385–400
2. Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29: 533–540
3. Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu W-J, Hwu P, Bedikian A (2011) Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117: 1687–1696
4. Patel JK, Didolkar MS, Pickren JW, Moore RH (1978) Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135: 807–810
5. Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W, Trefzer U (2006) Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 76: 59–64
6. Kim G, McKee AE, Ning Y-M et al (2014) FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAF V600E mutation. Clin Cancer Res Off J Am Assoc Cancer Res. doi: 10.1158/1078-0432.CCR-14-0776
7. Graziani G, Tentori L, Navarra P (2012) Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. Pharmacol Res 65: 9–22
8. Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363: 711–723
9. Queirolo P, Spagnolo F, Ascierto PA et al (2014) Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases. J Neurooncol. doi: 10.1007/s11060-014-1400-y
10. Di Giacomo AM, Ascierto PA, Pilla L et al (2012) Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial. Lancet Oncol 13: 879–886
11. Knisely JPS, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VLS (2012) Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg 117: 227–233
12. Silk AW, Bassetti MF, West BT, Tsien CI, Lao CD (2013) Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med 2: 899–906
13. Prins RM, Vo DD, Khan-Farooqi H, Yang M-Y, Soto H, Economou JS, Liau LM, Ribas A (2006) NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. J Immunol 177: 8448–8455
14. Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, Shirato H, Kitamura H, Nishimura T (2010) Local radiation therapy inhibits tumor growth through the generation of tumorspecific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 70: 2697–2706
15. Hamilton R, Krauze M, Romkes M et al (2013) Pathologic and gene expression features of metastatic melanomas to the brain. Cancer 119: 2737–2746
16. Cao Y, Tsien CI, Shen Z, Tatro DS, Ten Haken R, Kessler ML, Chenevert TL, Lawrence TS (2005) Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol Off J Am Soc Clin Oncol 23: 4127–4136
17. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system. J Clin Oncol 22: 2865–2872
18. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94: 2698–2705
19. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK (1978) Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival. Cancer 42: 660–668
20. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88: 11–20
21. Raizer JJ, Hwu W-J, Panageas KS et al (2008) Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-Oncol 10: 199–207
22. Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu W-J, Homsi J, Davies M, McIntyre S, Hwu P (2011) Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma. Am J Clin Oncol 34: 603–610
23. Schoenewolf NL, Belloni B, Simcock M, Tonolla S, Vogt P, Scherrer E, Holzmann D, Dummer R (2014) Clinical implications of distinct metastasizing preferences of different melanoma subtypes. Eur J Dermatol EJD. doi: 10.1684/ejd.2014.2292
24. Gumusay O, Coskun U, Akman T et al (2014) Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology. J Cancer Res Clin Oncol 140: 151–157
25. Papadatos-Pastos D, Soultati A, Harries M (2013) Targeting brain metastases in patients with melanoma. Bio Med Res Int 2013: 1–6
26. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19: 579–592